A Prognostic Index for Patients with Refractory or in First Relapsed Acute Myeloid Leukemia Treated with FLAG-Ida or Flago-Ida

被引:0
|
作者
Miguel Bergua, Juan [1 ]
Montesinos, Pau [2 ]
Martinez-Cuadron, David [3 ]
Fernandez-Abellan, Pascual [4 ]
Serrano, Josefina [5 ]
Jose Sayas, Maria [6 ]
Prieto-Fernandez, Julio [7 ]
Garcia, Raimundo [8 ]
Julia Garcia-Huerta, Ana [9 ]
Barrios, Manuel [10 ]
Perez-Lopez, Cristina [11 ]
Perez-Encinas, Manuel [12 ]
Siemele, Adriana [13 ]
Rodriguez-Macias, Gabriela [11 ]
Herrera-Puente, Pilar [11 ]
Rodriguez-Veiga, Rebeca [2 ]
Pilar Martinez-Sanchez, Maria [11 ]
Lourdes Amador-Barciela, Maria [13 ]
Sanz, Miguel A. [3 ,14 ,15 ,16 ]
机构
[1] PETHEMA Cooperat Grp, Caceres, Spain
[2] Hosp Univ & Politecn La Fe, Valencia, Spain
[3] PETHEMA Cooperat Grp, Valencia, Spain
[4] PETHEMA Grp, Spanish Soc Hematol, Badalona, Spain
[5] Hosp Univ Reina Sofia, Cordoba, Spain
[6] PETHEA Cooperat Gropu, Valencia, Spain
[7] Hosp San Pedro de Alcantara Caceres, Caceres, Spain
[8] Hosp Univ Gen Castellon, Castellon de La Plana, Spain
[9] PETHEMA Cooperat Grp, Oviedo, Spain
[10] PETHEMA Cooperat Grp, Malaga, Spain
[11] PETHEMA Cooperat Grp, Madrid, Spain
[12] PETHEMA Cooperat Grp, Santiago De Compostela, Spain
[13] PETHEMA Cooperat Grp, Pontevedra, Spain
[14] HOVON Cooperat Grp, Valencia, Spain
[15] PALG Cooperat Grp, Valencia, Spain
[16] GATLA Cooperat Grp, Valencia, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [31] FLAG-(IDA)-Mylotarg in the therapy of relapsed and refractory acute myeloid leukemia.
    Fabbiano, F
    Mondello, F
    Magrin, S
    Felice, R
    Marino, C
    Turri, D
    Mirto, S
    BLOOD, 2005, 106 (11) : 236B - 236B
  • [32] FLAG-IDA FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA: A SINGLE CENTRE 5-YEAR STUDY
    Agbuduwe, C.
    Follows, G.
    Craig, J.
    Uttenthal, B.
    Crawley, C.
    Krishnamurthy, P.
    HAEMATOLOGICA, 2017, 102 : 385 - 385
  • [33] Outcomes of FLAG-IDA Versus MEC in Relapsed or Refractory AML
    Bouligny, Ian M.
    Murray, Graeme
    Tran, Valerie
    Gor, Juhi
    Hang, Yiwei
    Alnimer, Yanal
    Zacholski, Kyle
    Venn, Chad
    Maher, Keri
    BLOOD, 2022, 140 : 11742 - 11743
  • [34] FLAG-IDA REGIMEN IN THE TREATMENT OF REFRACTORY/RELAPSED ACUTE MYELOBLASTIC LEUKEMIA: SINGLE-CENTER EXPERIENCE
    Genadieva-Stavrik, G.
    Georgievski, B.
    Cevreska, L.
    Karanfilski, O.
    Pivkova, A.
    Stojanoski, Z.
    Krstevska-Balkanov, S.
    Dukovski, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 560 - 561
  • [35] Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia
    Dinardo, Courtney D.
    Jen, Wei-Ying
    Takahashi, Koichi
    Kadia, Tapan M.
    Loghavi, Sanam
    Daver, Naval G.
    Xiao, Lianchun
    Reville, Patrick K.
    Issa, Ghayas C.
    Short, Nicholas J.
    Sasaki, Koji
    Wang, Sa A.
    Mullin, Jillian K.
    Pierce, Sherry
    Bradley, Corey
    Borthakur, Gautam
    Maiti, Abhishek
    Alvarado, Yesid
    Pemmaraju, Naveen
    Ferrajoli, Alessandra
    Swaminathan, Mahesh
    Ohanian, Maro
    Abbas, Hussein A.
    Hammond, Danielle
    Burger, Jan
    Haddad, Fadi
    Montalban-Bravo, Guillermo
    Chien, Kelly
    Masarova, Lucia
    Yilmaz, Musa
    Jain, Nitin
    Andreeff, Michael
    Garcia-Manero, Guillermo
    Kornblau, Steven
    Ravandi, Farhad
    Jabbour, Elias
    Konopleva, Marina Y.
    Kantarjian, Hagop M.
    LEUKEMIA, 2025, : 854 - 863
  • [36] FLAG-IDA or venetoclax in previously treated TP53mut acute myeloid leukemia
    Tran, Valerie
    Bouligny, Ian Michael
    Murray, Graeme
    Patel, Tilak
    Doyel, Michael
    Boron, Josh
    Gor, Juhi
    Hang, Yiwei
    Ho, Thuy
    Zacholski, Kyle
    Venn, Chad Michael
    Alnimer, Yanal Mufeed
    Wages, Nolan
    Grant, Steven
    Maher, Keri Renee
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [37] FLAG-IDA Has Significant Activity As Frontline Induction or Salvage Therapy for Patients with High Risk and/or Relapsed or Refractory Acute Myeloid Leukemia (AML)
    Bhella, Sita D.
    Atenafu, Eshetu G.
    Schuh, Andre C.
    Minden, Mark D.
    Schimmer, Aaron D.
    Gupta, Vikas
    Seftel, Matthew D.
    Alam, Naheed
    Lutynski, Andrzej
    Rostom, Amr
    Rydlewski, Anna
    Yee, Karen
    BLOOD, 2014, 124 (21)
  • [38] Relapsed or primary refractory AML: moving past MEC and FLAG-ida
    Koenig, Kristin
    Mims, Alice
    CURRENT OPINION IN HEMATOLOGY, 2020, 27 (02) : 108 - 114
  • [39] Sequential treatment with FLAG-IDA/treosulfan conditioning regimen for patients with active acute myeloid leukemia
    Liat Shargian-Alon
    Ofir Wolach
    Uri Rozovski
    Dafna Yahav
    Michal Sela-Navon
    Mazal Rubinstein
    Nino Oniashvilli
    Oren Pasvolsky
    Pia Raanani
    Moshe Yeshurun
    Annals of Hematology, 2020, 99 : 2939 - 2945
  • [40] Sequential treatment with FLAG-IDA/treosulfan conditioning regimen for patients with active acute myeloid leukemia
    Shargian-Alon, Liat
    Wolach, Ofir
    Rozovski, Uri
    Yahav, Dafna
    Sela-Navon, Michal
    Rubinstein, Mazal
    Oniashvilli, Nino
    Pasvolsky, Oren
    Raanani, Pia
    Yeshurun, Moshe
    ANNALS OF HEMATOLOGY, 2020, 99 (12) : 2939 - 2945